{"id":5361,"date":"2022-06-14T11:14:18","date_gmt":"2022-06-14T10:14:18","guid":{"rendered":"https:\/\/touchimmunology.com\/?post_type=media_gallery&p=5361"},"modified":"2022-06-14T11:14:18","modified_gmt":"2022-06-14T10:14:18","slug":"daniel-chappell-eular-2022","status":"publish","type":"media_gallery","link":"https:\/\/touchimmunology.com\/rheumatology\/conference-hub\/daniel-chappell-eular-2022\/","title":{"rendered":"Daniel Chappell, EULAR 2022: Osteoporosis Screening in Routine CT-based Diagnostic Scans"},"content":{"rendered":"

It was a pleasure to talk with <\/span>Daniel Chappell<\/strong> (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) around the feasibility study investigating rates of osteoporosis in people undergoing routine diagnostic CT scans and the potential of routine osteoporosis screening in future clinical practice.<\/p>\n

The abstract ‘Osteoporosis case-finding in people undergoing routine diagnostic CT scans almost tripled the rate of osteoporosis treatment at 12 months. A randomised, multi-centre feasibility study using waiting room FRAX, opportunistic CT bone density and vertebral fracture assessment versus usual care.<\/b>‘ (Abstract number: <\/span>OP0243<\/span>) was presented at the European Congress of Rheumatology 2022, 1-4 June, 2022.<\/span><\/p>\n

Questions<\/b><\/p>\n

    \n
  1. How often is osteoporosis found in CT scans taken for other reasons?\u00a0<\/span>(0:11)<\/span><\/li>\n
  2. What were the objectives, design and eligibility criteria of your study?\u00a0<\/span>(0:41)<\/span><\/li>\n
  3. What were the primary and secondary outcome measures, and what were the results? (1:24)<\/span><\/li>\n
  4. What would be the potential clinical impact of embedding osteoporosis screening into CT-based diagnostic scans? (3:37)
    \n<\/span><\/li>\n
  5. What questions remain unanswered and what future studies are planned? (5:13)
    \n<\/span><\/li>\n<\/ol>\n

    Disclosures:<\/b> Daniel Chappell has nothing to disclose in relation to this video interview.<\/span><\/p>\n

    Support:<\/b> Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.<\/span><\/p>\n

    Filmed in coverage of the EULAR meeting 2022.<\/i><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"

    It was a pleasure to talk with Daniel Chappell (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) around the feasibility study investigating rates of osteoporosis in people undergoing routine diagnostic CT scans and the potential of routine osteoporosis screening in future clinical practice. The abstract ‘Osteoporosis case-finding in people undergoing routine diagnostic CT scans almost […]<\/p>\n","protected":false},"featured_media":5483,"template":"","class_list":["post-5361","media_gallery","type-media_gallery","status-publish","has-post-thumbnail","hentry","vocabulary_1-rheumatology","video_categories-eular-highlights"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery\/5361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery"}],"about":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/types\/media_gallery"}],"version-history":[{"count":3,"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery\/5361\/revisions"}],"predecessor-version":[{"id":5484,"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery\/5361\/revisions\/5484"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media\/5483"}],"wp:attachment":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media?parent=5361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}